NCT06583824

Brief Summary

Acquired Swallowing Disorder in ICU (ICU-ASD), also known as postextubation dysphagia, is a multicausal problem experienced by survivors in intensive care units (ICUs) when the efficiency, safety of swallowing, or both are compromised. These alterations can lead to an increased risk of aspiration, respiratory complications, and malnutrition, potentially resulting in prolonged hospitalization, reduced quality of life, poorer clinical outcomes, and even death. Despite the clinical and social significance of this disorder, there is limited research addressing it. Existing studies primarily focus on incidence and associated factors, with scant attention to the occurrence of complications, and there is a lack of assessment of the quality of life of these patients. In our context, healthcare professionals are increasingly recognizing the importance of this issue, although the real incidence of ICU-ASD, as well as the frequency of respiratory and nutritional complications, remains unknown. Furthermore, the quality of life of patients with this disorder has not been evaluated thus far. Objectives:Primary: To analyze the occurrence of respiratory and nutritional complications associated with ICU-ASD in patients intubated for ≥48 hours or tracheotomized in the Intensive Care Unit of the University Hospital Complex of Albacete (ICU CHUA) and identify potential factors related to their occurrence. Specific: To determine the incidence of ICU-ASD in the polyvalent ICU CHUA, assess the frequency of respiratory complications, evaluate nutritional status, assess quality of life, and determine the mortality of study participants. Material and Method: Prospective observational cohort study. Setting: Polyvalent ICU CHUA. Participants: Intubated patients for ≥48 hours or tracheotomized, with signed consent. Sampling: Consecutive. Sample size: 414 participants. Demographic/clinical variables. Outcome variables: Occurrence of respiratory complications, nutritional status, quality of life. Instruments: Modified Volume-Viscosity Swallowing Test (mV-VST), Swallowing Quality of Life Questionnaire (SWAL-QoL). Dysphagia detection will occur 24 hours post-extubation and/or 4 days after tracheotomy. Follow-up during hospitalization and post-ICU discharge until the outpatient consultation. Statistical analysis: Absolute and relative frequencies, measures of central tendency and dispersion, significance level of p \< 0.05, 95% CI; Bivariate analysis: Checking group homogeneity and hypothesis testing: Chi-square, Student\'s t-test, U-Mann-Whitney, ANOVA, or Kruskal-Wallis.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
414

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Sep 2024

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Sep 2024Sep 2026

First Submitted

Initial submission to the registry

September 2, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 4, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

September 10, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2025

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Expected
Last Updated

September 4, 2024

Status Verified

September 1, 2024

Enrollment Period

5 months

First QC Date

September 2, 2024

Last Update Submit

September 3, 2024

Conditions

Keywords

dysphagiatracheostomyaspirationmalnutritioncritical caremechanical ventilationpneumonia

Outcome Measures

Primary Outcomes (1)

  • Respiratory Complications

    Pneumonia: when a new pulmonary infiltrate or progression appears on the chest x-ray, or cavitation or consolidation, associated with at least 2 of the following criteria: temperature \> 38oC, leukocyte count \> 12,000/mm3 or leukocytopenia \< 4,000/mm3, purulent orotracheal secretion or change in the characteristic of sputum, increased secretions and need for greater suction, new respiratory sounds or rales, worsening oxygenation. tracheobronchitis: clinical syndrome similar to pneumonia that must meet at least 2 of the aforementioned criteria, without radiographic infiltrate present.

    This outcome variable may appear from the completion of the mV-VST until the end of participation 90 days after hospital discharge.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients admitted to the multidisciplinary ICU at CHUA who require intubation or tracheostomy during their stay. CHUA is a tertiary-level hospital with approximately 700 beds, and it is part of the Integrated Healthcare Management of Albacete under the Health Service of Castilla-La Mancha (SESCAM). The multidisciplinary Intensive Care Unit is located on the second floor, central area, of the General Hospital. It is a general (multidisciplinary) unit that manages all critical pathologies (along with other critical care units in the Hospital Complex) except for pediatric cases. The multidisciplinary ICU currently has 18 functional beds, and the majority of admissions are due to medical conditions.

You may qualify if:

  • Patients aged ≥ 18 years, requiring intubation for ≥ 48 hours and/or subsequent tracheostomy, with an adequate level of consciousness to perform the dysphagia diagnostic test, and who have signed the consent form.

You may not qualify if:

  • Previous tracheostomy, prior diagnosis of dysphagia, neurodegenerative disease, or a history of stroke (CVA).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Macht M, Wimbish T, Bodine C, Moss M. ICU-acquired swallowing disorders. Crit Care Med. 2013 Oct;41(10):2396-405. doi: 10.1097/CCM.0b013e31829caf33.

    PMID: 23939361BACKGROUND
  • McInytre M, Doeltgen S, Shao C, Chimunda T. The incidence and clinical outcomes of postextubation dysphagia in a regional critical care setting. Aust Crit Care. 2022 Mar;35(2):107-112. doi: 10.1016/j.aucc.2021.03.008. Epub 2021 May 24.

    PMID: 34034939BACKGROUND
  • Schefold JC, Berger D, Zurcher P, Lensch M, Perren A, Jakob SM, Parviainen I, Takala J. Dysphagia in Mechanically Ventilated ICU Patients (DYnAMICS): A Prospective Observational Trial. Crit Care Med. 2017 Dec;45(12):2061-2069. doi: 10.1097/CCM.0000000000002765.

    PMID: 29023260BACKGROUND
  • Martinez de Lagran Zurbano I, Laguna LB, Soria CV, Guisasola CP, Marcos-Neira P. Utility of the modified Volume-Viscosity Swallow Test for bedside screening of dysphagia in critically ill patients. Clin Nutr ESPEN. 2023 Feb;53:214-223. doi: 10.1016/j.clnesp.2022.12.021. Epub 2022 Dec 23.

    PMID: 36657916BACKGROUND
  • Zaldibar-Barinaga MB, Miranda-Artieda M, Zaldibar-Barinaga A, Pinedo-Otaola S, Erazo-Presser P, Tejada-Ezquerro P. Versión española del Swallowing Quality of Life Questionnaire: fase inicial de adaptación transcultural. Rehabilitación. 2013;47(3):136-40.

    BACKGROUND
  • McIntyre M, Doeltgen S, Dalton N, Koppa M, Chimunda T. Post-extubation dysphagia incidence in critically ill patients: A systematic review and meta-analysis. Aust Crit Care. 2021 Jan;34(1):67-75. doi: 10.1016/j.aucc.2020.05.008. Epub 2020 Jul 29.

    PMID: 32739246BACKGROUND
  • Skoretz SA, Flowers HL, Martino R. The incidence of dysphagia following endotracheal intubation: a systematic review. Chest. 2010 Mar;137(3):665-73. doi: 10.1378/chest.09-1823.

    PMID: 20202948BACKGROUND

MeSH Terms

Conditions

PneumoniaDeathDeglutition DisordersMalnutrition

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesNutrition DisordersNutritional and Metabolic Diseases

Central Study Contacts

Francisca CALERO YAÑEZ, grado en enfermeria

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Graduada en Enfermeria

Study Record Dates

First Submitted

September 2, 2024

First Posted

September 4, 2024

Study Start

September 10, 2024

Primary Completion

February 15, 2025

Study Completion (Estimated)

September 30, 2026

Last Updated

September 4, 2024

Record last verified: 2024-09